Among 5 analysts covering Hydrogenics (NASDAQ:HYGS), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Hydrogenics had 18 analyst reports since August 14, 2015 according to SRatingsIntel. Cowen & Co maintained the stock with “Hold” rating in Thursday, September 14 report. Rodman & Renshaw maintained the shares of HYGS in report on Tuesday, November 8 with “Buy” rating. The stock has “Hold” rating by Cowen & Co on Monday, October 16. The stock of Hydrogenics Corporation (NASDAQ:HYGS) earned “Buy” rating by TH Capital on Monday, November 16. Cowen & Co maintained Hydrogenics Corporation (NASDAQ:HYGS) on Monday, July 10 with “Hold” rating. The stock has “Buy” rating by Roth Capital on Monday, July 31. The firm has “Buy” rating by Roth Capital given on Friday, October 27. The stock of Hydrogenics Corporation (NASDAQ:HYGS) earned “Buy” rating by Roth Capital on Wednesday, February 3. Roth Capital maintained the stock with “Buy” rating in Saturday, August 15 report. The firm has “Buy” rating by Roth Capital given on Friday, January 19. See Hydrogenics Corporation (NASDAQ:HYGS) latest ratings:
19/01/2018 Broker: Roth Capital Rating: Buy New Target: $14.0 Maintain
27/10/2017 Broker: Roth Capital Rating: Buy New Target: $11.0 Maintain
16/10/2017 Broker: Cowen & Co Rating: Hold New Target: $9.0 Maintain
14/09/2017 Broker: Cowen & Co Rating: Hold New Target: $9.0 Maintain
11/08/2017 Broker: Cowen & Co Rating: Hold New Target: $9.0000 Maintain
The stock of IKONICS Corporation (NASDAQ:IKNX) hit a new 52-week low and has $6.94 target or 6.00% below today’s $7.38 share price. The 6 months bearish chart indicates high risk for the $14.70 million company. The 1-year low was reported on Feb, 9 by Barchart.com. If the $6.94 price target is reached, the company will be worth $882,120 less. The stock decreased 4.77% or $0.37 during the last trading session, reaching $7.38. About 3,262 shares traded or 462.41% up from the average. IKONICS Corporation (NASDAQ:IKNX) has declined 21.10% since February 9, 2017 and is downtrending. It has underperformed by 37.80% the S&P500.
IKONICS Corporation develops, manufactures, and sells photosensitive liquids and films for the screen printing, and awards and recognition industries primarily in the United States. The company has market cap of $14.70 million. It operates through five divisions: Domestic, Export, IKONICS Imaging, Digital Texturing Technology, and Advanced Material Solutions. It currently has negative earnings. The firm sells screen printing films, emulsions, and inkjet receptive films to distributors; and photo resistant films, art supplies, glass, metal medium, and related abrasive etching equipment to end user customers.
Investors sentiment is 1 in Q3 2017. Its the same as in 2017Q2. It has no change, as 1 investors sold IKONICS Corporation shares while 0 reduced holdings. only 0 funds opened positions while 1 raised stakes. 28,848 shares or 1.05% more from 28,548 shares in 2017Q2 were reported. Royal Financial Bank Of Canada holds 0% or 4,300 shares. Blackrock holds 0% or 237 shares. Us Savings Bank De holds 0% of its portfolio in IKONICS Corporation (NASDAQ:IKNX) for 11,842 shares. Jnba Financial Advsr stated it has 0.02% in IKONICS Corporation (NASDAQ:IKNX). Morgan Stanley holds 0% or 1,845 shares.
Hydrogenics Corporation, together with its subsidiaries, designs, develops, and makes hydrogen generation products based on water electrolysis technology; and fuel cell products based on proton exchange membrane technology. The company has market cap of $124.14 million. It operates in two divisions, OnSite Generation and Power Systems. It currently has negative earnings. The OnSite Generation segment develops products for industrial gas, hydrogen fueling, and renewable energy storage markets.